Could Roivant Sciences Be a Multibagger Stock Soon
Biotech investing offers life-changing upside, but it also comes with steep risks. This guide breaks down whether cou...
Looking for ways to make extra cash on weekends? Discover flexible gigs that can help you boost your income during your off days.
20,118 articlesBiotech investing offers life-changing upside, but it also comes with steep risks. This guide breaks down whether cou...
SpaceX’s rapid move into index funds signals a shift in how private tech breakthroughs reach everyday investors. This...
Oil prices rise and equity futures turn lower as tensions with Iran fresh escalate. Investors brace for higher energy...
Bitcoin hovered around $64,000 this week after a modest rally, but key on-chain levels remain out of reach. Analysts ...
Nvidia remains the marquee name in the 2026 AI stock rally, while AMD gains ground and Palantir stalls. Analysts sket...
Jeff Bezos-led Blue Origin plans a $10 billion external round at a $130 billion valuation, a move that reframes priva...
CoreWeave’s billion funding haul underscores a shifting liquidity landscape, with AI infrastructure drawing tens of b...
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
GE Aerospace delivered strong results in 2026, but the broader XLI index outpaced the stock through July. Here's what...
Velocity closes a $38 million Series A to scale stablecoin-enabled payments for cross-border settlements, backed by a...
Citigroup is up about 14% year-to-date through mid-July 2026, outpacing Bank of America and Wells Fargo. AI-driven tr...
In 2025, the U.S. minted 441,000 new millionaires as the median American wealth contracted, underscoring a split econ...